Session Type
Meeting
Search Results for Opioid
Abstract Number: D12
SHM Converge 2022
Background: Neonatal abstinence syndrome (NAS) occurs when a neonate is exposed to licit or illicit chemical substances in utero and manifests withdrawal symptoms postnatally. Appropriate identification, documentation, and communication of NAS diagnosis is needed to qualify for federally funded therapies aimed at supporting development through early intervention (EI) programs. Our objective was to assess characteristics […]
Abstract Number: D13
SHM Converge 2022
Background: Hospitalists are at the forefront of the opioid epidemic. Over half of hospitalized patients are exposed to opioids during their admission, most of whom are opioid naïve.1 Patients discharged on opioids have a 15% chance of long-term use after one year.2 There is significant variation in provider opioid prescribing practices, even within the same […]
Abstract Number: F18
SHM Converge 2022
Background: In utero opioid exposure can result in neonatal abstinence syndrome (NAS). NAS is a serious condition characterized by central nervous system hyperirritability and autonomic nervous system and gastrointestinal tract dysfunction. Newborns with NAS may require pharmacological management, have increased hospital costs, and have a prolonged hospital length of stay (LOS). NAS incidence has increased […]
Abstract Number: I11
SHM Converge 2022
Background: Opioid analgesia is an important treatment modality for patients with chronic pain, including pain attributed to cancer- and noncancer-related illness. Unfortunately, an estimated 40%–80% of opioid users experience opioid-induced constipation (OIC). Methylnaltrexone (MNTX) is indicated for the treatment of OIC. In clinical trials, the most common adverse events (AEs) were gastrointestinal (GI) in nature. […]
Abstract Number: M27
SHM Converge 2022
Case Presentation: A 34 year old male with a medical history of polysubstance abuse and hypothyroidism presented from subacute rehab after a combined thoracolumbar and sacral fixation surgery with worsening generalized weakness. The patient described deconditioning with increased difficulty standing despite 3-4 hours of daily physical therapy. Other acute symptoms included insomnia and mood swings. […]
Abstract Number: M29
SHM Converge 2022
Case Presentation: Central Adrenal Insufficiency (CAI) is a rare and often late diagnosis due to nonspecific signs, such as fatigue, hyponatremia, electrolyte abnormalities and fever of unknown origin (FUO). CAI suspicion arises in patients with pituitary tumors, cranial irradiation, surgery, injury, infection, exogenous glucocorticoid withdrawal, and less commonly known, opioid use disorder. A 31-year-old male […]
Abstract Number: M30
SHM Converge 2022
Case Presentation: A 56-year-old man with active polysubstance use disorder including daily intranasal heroin and cocaine use and previous abdominal surgery was admitted with a week of abdominal pain and constipation. His last bowel movement was one week prior to admission, though he did report ongoing flatus without nausea or vomiting. The abdomen was diffusely […]
Abstract Number: P40
SHM Converge 2022
Case Presentation: A 19-year-old female with a history of opioid use disorder (OUD) presented to the Emergency Department with abdominal pain, fever, and severe hypotension several days after relapsing with intravenous heroin following two years of successful maintenance on buprenorphine. She was admitted to the intensive care unit for treatment of severe sepsis including broad-spectrum […]
Abstract Number: 1206
Hospital Medicine 2020, Virtual Competition
Background: To curb the growing opioid epidemic, hospitalists need to re-examine inpatient opioid use and increase utilization of alternatives to opioids for pain management. Of 1.1 million nonsurgical inpatients across 286 US hospitals from July 2009 to June 2010, 51% received an opioid during hospitalization and more than half with inpatient exposure were prescribed opioids […]
Oral Presentations
Abstract Number: Oral
SHM Converge 2021
Background: Despite evidence that the use of medications for patients with opioid use disorder (OUD) leads to reduced mortality and improved engagement in outpatient addiction treatment, these life-saving medications are underutilized in the hospital setting. This study reports the outcomes of a hospitalist-led interprofessional and multidisciplinary inpatient program, known as the B-Team (buprenorphine team), to […]